An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19
- PMID: 32240283
- PMCID: PMC7138407
- DOI: 10.7326/M20-1141
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19
Abstract
The COVID-19 pandemic is a particularly grave risk to the millions of Americans with opioid use disorder, who—already vulnerable and marginalized—are heavily dependent on face-to-face health care delivery. These authors propose rapid and coordinated action on the part of clinicians and policymakers to mitigate risks of disrupted care for these patients.
Keywords: COVID-19; Food; Health care; Health care providers; Medicare; Opioid addiction; Opioids; Patients; Safety; Telemedicine.
References
-
- Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Imperial College COVID-19 Response Team. Accessed at www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowsh.... on 30 March 2020.
-
- Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. HHS Publication No. (SMA) PEP15-FEDGUIDEOTP. Substance Abuse and Mental Health Services Administration; 2015.
-
- Substance Abuse and Mental Health Services Administration. Opioid Treatment Program (OTP) Guidance. Accessed at www.samhsa.gov/sites/default/files/otp-guidance-20200316.pdf. on 16 March 2020.
-
- U.S. Department of Justice, Drug Enforcement Administration. COVID_19 Information Page: Telemedicine. Accessed at www.deadiversion.usdoj.gov/coronavirus.html. on 18 March 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical